New treatment of non-small cell lung cancer
TW202629598APending Publication Date: 2026-07-16PIERRE FABRE MEDICAMENT SAS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141130
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-24
- Filing Date
- 2025-10-23
- Publication Date
- 2026-07-16
Abstract
The present invention discloses a method for treating cancerous tumours and / or metastasis with MET mutations and / or amplifications using an anti-MET antibody fragment. The method involves administering the antibody fragment, which features a single antigen-binding arm and a silenced Fc region, in effective doses ranging from 350 mg to 5000 mg. This dosage regimen is intended for the effective treatment of cancer, in particular NSCLC.
Need to check novelty before this filing date? Find Prior Art